Geoff MacKay, CEO of Organogenesis, spoke at last year's Stem Cells & Regenerative Medicine Congress, on the topic âThe path to a CBER FDA allogeneic cell therapy approval.'
Download his presentation slides for insights on:
- Organogenesis platform cellular technology
- Overview of development timeline
- FDA review team structure
- Regulatory review milestones
- Transition to commercialization